Deflazacort

What is it?

Composition

Deflazacort contains the active substance deflazacort, a synthetic glucocorticoid. In tablets, it is combined with standard excipients such as fillers, binders, disintegrants, and lubricants to form an oral solid dosage form.

How to use?

Deflazacort tablets are taken by mouth, usually once daily.

Typical dosing in Duchenne muscular dystrophy is around 0.9 mg/kg once daily, with the prescriber adjusting for weight changes and tolerability. Deflazacort may be taken with or without food; taking it with food can reduce nausea for some people.

A practical way clinicians structure administration:

1. Take the full daily dose at the same time each day (many use morning dosing).
2. Keep dosing consistent across weekdays and weekends unless the specialist plan says otherwise.
3. If stomach upset happens, pair the dose with a meal.
4. Expect dose changes over time as weight and side effects change.

Never stop suddenly after regular use. Adrenal suppression can occur with systemic corticosteroids, and tapering plans exist for a reason.

How does it work?

• Take the tablets orally.
• Usual adult dose: 6–90 mg/day, given as 1–2 doses per day depending on the indication and prescriber instructions.
• Take the dose with food or after meals to reduce stomach irritation.
• Prefer taking it in the morning when a once-daily regimen is prescribed.
• For long-term treatment, the duration is set individually and the dose should be reduced gradually only under medical supervision.
• In children, dosing is usually calculated in mg/kg/day and must be prescribed by a specialist.

Indications

Deflazacort is a corticosteroid medicine. In day-to-day prescribing, clinicians use it when they want a steroid effect (anti-inflammatory + immunosuppressant) with dosing that can be adjusted carefully over time.

Its best-known use is Duchenne muscular dystrophy, where ongoing inflammation in muscle tissue contributes to functional decline. Deflazacort can help preserve muscle strength and slow loss of function for some patients with DMD, so it is used as part of long-term management plans in specialist neuromuscular care ^[1].

For other conditions, deflazacort may be selected when steroid therapy is needed to control inflammation or immune activity (for example, steroid-responsive inflammatory flares), with the exact indication depending on the treating team’s plan and monitoring.

Comparison

Deflazacort and Prednisolone are both corticosteroids used for inflammatory conditions. Clinicians often consider them broadly comparable in steroid effect, then choose based on patient goals, tolerability, and long-term risk priorities.

Some prescribers favor deflazacort in long-term regimens, such as DMD management, because it may have a more favorable profile for certain metabolic and bone-related outcomes versus prednisolone in some settings, while still providing glucocorticoid activity. Prednisolone remains widely used, familiar, and comes in many dosing strategies including low-dose regimens (people often reference “5 mg prednisolone” as a common small-dose step).

The key decision is which plan best balances function versus long-term complications for the individual patient.

Contraindications

• Known allergy or hypersensitivity to deflazacort
• Use in children under two years of age
• Live vaccines given within a clinically relevant window around treatment
• Grapefruit or grapefruit juice during therapy

Also use extra caution (specialist-led decision) with uncontrolled infections, severe osteoporosis, uncontrolled diabetes, or severe psychiatric instability.

Not recommended for

Tell the treating team if you have a current or recent infection, diabetes or pre-diabetes, osteoporosis risk, peptic ulcer disease, eye problems such as glaucoma or cataracts, or a significant mood disorder history. Long-term steroid courses may also need monitoring of weight, blood pressure, glucose, and bone health.

Side effects

Deflazacort side effects range from nuisance effects to clinically important problems, and risk increases with higher doses and longer courses.

Commonly reported or clinically expected effects with systemic corticosteroids include:

• Weight gain and increased appetite
• Fluid retention and swelling
• Mood and behavior changes (irritability, low mood, restlessness)
• Stomach upset, nausea, or vomiting
• Raised blood pressure
• Blood sugar elevation, with special concern in diabetes
• Higher susceptibility to infection

Two symptoms that need faster medical assessment during steroid therapy are fever and sudden confusion. Fever can signal infection, and confusion can signal a serious systemic effect, severe infection, or a steroid-related neuropsychiatric reaction. Unusual or allergic reaction to deflazacort can show as rash, facial swelling, wheeze, or trouble breathing.

Common mistakes

• Stopping suddenly after weeks or months of daily dosing, which can trigger steroid withdrawal symptoms and adrenal suppression.
• Taking the dose late in the day and then blaming the medicine for insomnia without trying earlier dosing first.
• Ignoring early infection signs (a new cough, burning urine, mouth thrush) because there is no high fever at the start.
• Treating increased appetite as “just willpower,” instead of planning higher-protein meals and structured snacks to limit rapid weight gain.
• Getting vaccines without flagging steroid therapy status; live vaccines need careful timing with immunosuppressive dosing plans.

One more real-world nuance: some families chase “better strength” by self-adjusting the dose. It often backfires with mood changes, swelling, and sleep disruption.

Doctor opinions

Neuromuscular specialists also watch for a pattern that families may miss: small behavior shifts (irritability, emotional lability, new anxiety) can be dose-related rather than “just stress.” When caught early, clinicians can adjust timing, dose, or supportive measures without losing the functional benefit.

From a safety standpoint, physicians take the immunosuppression effect seriously. A fever that would be “minor” without steroids may deserve faster assessment during steroid therapy because infections can escalate more quickly.

Frequently asked questions

Is Deflazacort mainly used for Duchenne muscular dystrophy?

Yes. Deflazacort is widely recognized for its role in Duchenne muscular dystrophy (DMD) care, where it can help preserve muscle function and slow decline in some patients. Current clinical practice still uses it as part of a broader plan that includes physiotherapy, respiratory follow-up, and nutrition support. Benefits are judged over months, not days.

How fast does Deflazacort reduce inflammation and swelling?

Deflazacort can reduce inflammation and swelling within days to a couple of weeks when the condition is steroid-responsive, because glucocorticoids switch down inflammatory gene signaling ^[5]. Clinicians usually evaluate early response using symptom change plus objective measures like swelling, range of motion, or functional testing. For DMD, improvement is more gradual and assessed on specialist follow-up schedules.

Can Deflazacort cause confusion or fever?

Yes. Confusion can occur as a serious steroid-related neuropsychiatric effect, or as a sign of systemic illness that needs urgent assessment. Fever matters because deflazacort suppresses immune activity, so infections can progress faster or present atypically. WHO safety communications about systemic corticosteroids emphasize infection vigilance as a core risk theme for this drug class, and the 2025 update reinforces that point.

Why are live vaccines listed as a restriction with Deflazacort?

Live vaccines can be unsafe or less effective in people taking immunosuppressive doses of corticosteroids, because the immune system response is reduced. Deflazacort can lower the body’s ability to control even weakened live organisms used in some vaccines. EMA prescribing standards for systemic corticosteroids include clear cautions around live immunisation timing, reflected in 2025 regulatory materials for corticosteroid-class medicines.

Is grapefruit really an issue with Deflazacort?

Grapefruit and grapefruit juice can change the metabolism of many medicines, including some corticosteroids, by affecting intestinal and liver enzymes. With deflazacort, this can increase steroid exposure in some people, which may raise the risk of side effects like swelling, mood changes, and higher blood sugar. MOHAP-aligned medication counseling in the UAE commonly flags grapefruit as a practical interaction point for CYP3A-influenced medicines, and 2025 patient-safety materials reinforce that advice.

How does Deflazacort compare with Prednisolone?

Both Deflazacort and Prednisolone are corticosteroids, used to reduce inflammation and suppress immune activity. The real difference is usually tolerability and the long-term monitoring plan, not a simple “better vs worse” label. Some clinicians prefer deflazacort for longer-term plans in DMD because of perceived advantages in certain metabolic or bone outcomes, while prednisolone remains a very common choice across many inflammatory conditions. EMA class guidance and clinical reviews in 2025 continue to frame steroid choice as individualized, with side-effect prevention built into the plan.

Do you offer anonymous delivery?

Front view

Side view

Back view

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.